|
Volumn 10, Issue 1, 2009, Pages 18-26
|
Understanding the importance of vitamin D for bone and systemic health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,25 DIHYDROXYERGOCALCIFEROL;
25 HYDROXYVITAMIN D;
CALCITRIOL;
CALCIUM;
CALCIUM CARBONATE;
CALCIUM PHOSPHATE;
CITRACAL D;
COLECALCIFEROL;
ERGOCALCIFEROL;
MAGNESIUM;
OSTELIN VITAMIN D;
OSTEOBLAST (DRUG);
OSTEVIT D;
PLACEBO;
UNCLASSIFIED DRUG;
BONE METABOLISM;
BREAST CANCER;
CANCER INHIBITION;
CANCER RISK;
CLINICAL TRIAL;
DIGESTIVE SYSTEM CANCER;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG SAFETY;
FALLING;
FRACTURE;
HUMAN;
HYPERPARATHYROIDISM;
HYPERTENSION;
IMMUNOREGULATION;
INNATE IMMUNITY;
INSULIN DEPENDENT DIABETES MELLITUS;
INTESTINE ABSORPTION;
MULTIPLE SCLEROSIS;
MUSCLE FUNCTION;
MYOPATHY;
OSTEOMALACIA;
OSTEOPOROSIS;
PSORIASIS;
RECOMMENDED DRUG DOSE;
REVIEW;
RISK REDUCTION;
SUNLIGHT;
UROGENITAL TRACT CANCER;
VITAMIN BLOOD LEVEL;
VITAMIN D DEFICIENCY;
VITAMIN D METABOLISM;
VITAMIN SUPPLEMENTATION;
|
EID: 60749085479
PISSN: 1443430X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (0)
|